Certara Inc at Bank of America Tech Solutions for Drug Discovery Conference (Virtual) Transcript
Good morning, and thank you for joining us. My name is Mike Ryskin, and I'm on the life science tools and diagnostics team here at Bank of America. We're excited to be hosting our first Tech Solutions for Drug Discovery Conference.
By way of intro, we really see this tech-enabled drug discovery topic as a growing new subsector in public markets, and it's a very exciting opportunity at the intersection of tools technologies, software technologies and computing and biotechnology. The underlying problem that these companies are all trying to address: less efficient R&D at pharma and biotech, lower ROI, falling success rates, higher cost of drugs development. They've all been well characterized and are well understood. But despite years of efforts, we haven't seen significant progress until now.
Using genomics, proteomics and other omics technologies to generate vast amounts of data about underlying human biology and then leveraging AI, machine learning and software algorithms to process these massive data sets
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |